Kevin R. Guertin

1.5k total citations
24 papers, 1.0k citations indexed

About

Kevin R. Guertin is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Kevin R. Guertin has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Genetics. Recurrent topics in Kevin R. Guertin's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Pancreatic function and diabetes (4 papers). Kevin R. Guertin is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Pancreatic function and diabetes (4 papers). Kevin R. Guertin collaborates with scholars based in United States, Switzerland and Canada. Kevin R. Guertin's co-authors include Joseph Grimsby, Andrew S. Kende, Lida Qi, Ramakanth Sarabu, Mark Dvorozniak, Joseph F. Grippo, Cheryl Spence, Robert F. Kester, Paige E. Mahaney and Nancy-Ellen Haynes and has published in prestigious journals such as Science, Blood and Journal of Bacteriology.

In The Last Decade

Kevin R. Guertin

22 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin R. Guertin United States 15 634 398 216 204 142 24 1.0k
Frédéric Massé Canada 18 749 1.2× 281 0.7× 131 0.6× 361 1.8× 135 1.0× 22 1.4k
Ramakanth Sarabu United States 19 923 1.5× 738 1.9× 449 2.1× 287 1.4× 113 0.8× 37 1.3k
James M. Fujitaki United States 18 585 0.9× 88 0.2× 218 1.0× 132 0.6× 94 0.7× 34 1.2k
Shaoxian Sun United States 17 611 1.0× 140 0.4× 61 0.3× 114 0.6× 58 0.4× 34 919
Diane K. Luci United States 13 488 0.8× 94 0.2× 61 0.3× 182 0.9× 61 0.4× 19 940
Kazuyuki Miyashita Japan 20 570 0.9× 107 0.3× 201 0.9× 391 1.9× 104 0.7× 65 1.2k
Donald Wojciechowicz United States 19 713 1.1× 48 0.1× 234 1.1× 284 1.4× 63 0.4× 31 1.5k
J.D. Priddle United Kingdom 19 785 1.2× 233 0.6× 70 0.3× 53 0.3× 170 1.2× 40 1.4k
Ursula Müller‐Vieira Germany 24 454 0.7× 158 0.4× 422 2.0× 225 1.1× 292 2.1× 29 1.5k
Sailen Mookerjea Canada 21 774 1.2× 138 0.3× 171 0.8× 152 0.7× 53 0.4× 96 1.3k

Countries citing papers authored by Kevin R. Guertin

Since Specialization
Citations

This map shows the geographic impact of Kevin R. Guertin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin R. Guertin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin R. Guertin more than expected).

Fields of papers citing papers by Kevin R. Guertin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin R. Guertin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin R. Guertin. The network helps show where Kevin R. Guertin may publish in the future.

Co-authorship network of co-authors of Kevin R. Guertin

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin R. Guertin. A scholar is included among the top collaborators of Kevin R. Guertin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin R. Guertin. Kevin R. Guertin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demers, Mélanie, Kevin R. Guertin, Dipti Gupta, et al.. (2021). MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease. Blood Advances. 5(5). 1388–1402. 5 indexed citations
2.
Banerjee, Daliya, Tonika Bohnert, Jianhua Chao, et al.. (2015). Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2985–2990. 27 indexed citations
3.
Chao, Jianhua, Istvan Enyedy, D.J. Marcotte, et al.. (2015). Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2991–2997. 27 indexed citations
4.
Banerjee, Daliya, Linlin Zhao, Lan Wu, et al.. (2015). Small molecule mediated inhibition of RORγ‐dependent gene expression and autoimmune disease pathology in vivo. Immunology. 147(4). 399–413. 33 indexed citations
5.
Gillespie, Paul, Michael C. Myers, Karin Conde‐Knape, et al.. (2014). Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(12). 2707–2711. 2 indexed citations
6.
Haynes, Nancy-Ellen, Wendy L. Corbett, Fred T. Bizzarro, et al.. (2010). Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675). Journal of Medicinal Chemistry. 53(9). 3618–3625. 36 indexed citations
7.
Brinkman, J. A., Alexander Flohr, Joseph Grimsby, et al.. (2010). 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: Drug-like and non-xanthine based A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(14). 4140–4146. 9 indexed citations
8.
Guertin, Kevin R., et al.. (2007). The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development. Current Medicinal Chemistry. 14(23). 2471–2481. 31 indexed citations
9.
Guertin, Kevin R. & Joseph Grimsby. (2006). Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy. Current Medicinal Chemistry. 13(15). 1839–1843. 62 indexed citations
10.
Grimsby, Joseph, Ramakanth Sarabu, Wendy L. Corbett, et al.. (2003). Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy. Science. 301(5631). 370–373. 408 indexed citations
11.
Guertin, Kevin R., Lida Qi, R. Dunsdon, et al.. (2003). Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 13(17). 2895–2898. 36 indexed citations
12.
13.
Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations
14.
Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations
15.
Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2001). Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673. Thrombosis Research. 103(4). 309–324. 23 indexed citations
16.
Klein, Scott I., Kevin R. Guertin, Daniel L. Cheney, et al.. (1998). Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(4). 437–450. 35 indexed citations
17.
Kende, Andrew S., et al.. (1996). SYNTHESIS OF SOME NOVEL FUNCTIONALIZED DOUBLE MICHAEL ACCEPTORS BASED ONbis(VINYLSULFONYL)METHANE (BVSM). Organic Preparations and Procedures International. 28(6). 683–690.
18.
Guertin, Kevin R. & Andrew S. Kende. (1993). Chemoselective catalytic oxidation of sulfides to sulfones with tetrapropylammonium perruthenate (TPAP). Tetrahedron Letters. 34(34). 5369–5372. 38 indexed citations
19.
Guertin, Kevin R. & Tak Hang Chan. (1991). Facile synthesis of α-hydroxy carbonyl compounds by enolate oxidation with dimethyldioxirane. Tetrahedron Letters. 32(6). 715–718. 43 indexed citations
20.
Chan, Tak Hang, et al.. (1990). Spruce budworm (Choristoneurafumiferana) antifeedants 2. Structure–activity relationship among some functionalized decalin compounds. Canadian Journal of Chemistry. 68(7). 1170–1177. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Massé Breakdown of academic impact, for papers by Ramakanth Sarabu Breakdown of academic impact, for papers by James M. Fujitaki Breakdown of academic impact, for papers by Shaoxian Sun Breakdown of academic impact, for papers by Diane K. Luci Breakdown of academic impact, for papers by Kazuyuki Miyashita Breakdown of academic impact, for papers by Donald Wojciechowicz Breakdown of academic impact, for papers by J.D. Priddle Breakdown of academic impact, for papers by Ursula Müller‐Vieira Breakdown of academic impact, for papers by Sailen Mookerjea
Rankless by CCL
2026